Psychosis among "healthy" siblings of schizophrenia patients.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 1434733)

Published in BMC Psychiatry on January 31, 2006

Authors

Ritva Arajärvi1, Jonna Ukkola, Jari Haukka, Jaana Suvisaari, Jukka Hintikka, Timo Partonen, Jouko Lönnqvist

Author Affiliations

1: Department of Mental Health and Alcohol Research, National Public Health Institute, Helsinki, Finland. ritva.arajarvi@ktl.fi

Articles cited by this

Longitudinal data analysis for discrete and continuous outcomes. Biometrics (1986) 60.93

The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry (1992) 7.36

The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl (1989) 4.53

The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch Gen Psychiatry (1993) 3.61

A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am J Hum Genet (1999) 2.15

Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch Gen Psychiatry (1995) 2.00

Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet (2001) 1.95

Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum Mol Genet (2003) 1.87

Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. Hum Mol Genet (2001) 1.57

Finnish adoptive family study: sample selection and adoptee DSM-III-R diagnoses. Acta Psychiatr Scand (2000) 1.56

A comparison of clinical and research DSM-III-R diagnoses of schizophrenia in a Finnish national birth cohort. Clinical and research diagnoses of schizophrenia. Soc Psychiatry Psychiatr Epidemiol (1997) 1.50

Replication of 1q42 linkage in Finnish schizophrenia pedigrees. Mol Psychiatry (2004) 1.49

The Roscommon Family Study. II. The risk of nonschizophrenic nonaffective psychoses in relatives. Arch Gen Psychiatry (1993) 1.23

Schizophrenia in the genetic isolate of Finland. Am J Med Genet (1997) 1.22

Inpatient diagnostic assessments: 1. Accuracy of structured vs. unstructured interviews. Psychiatry Res (2001) 1.17

Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort. Soc Psychiatry Psychiatr Epidemiol (2003) 1.16

Accuracy of register-based schizophrenia diagnoses in a genetic study. Eur Psychiatry (1998) 1.01

Morbidity risk of psychiatric disorders among the first degree relatives of schizophrenia patients in Taiwan. Schizophr Bull (2002) 1.01

Familial loading associates with impairment in visual span among healthy siblings of schizophrenia patients. Biol Psychiatry (2003) 1.01

The dichotomy of schizophrenia and affective disorders in extended pedigrees. Schizophr Res (2002) 0.97

A study of the interrelationship between and comparative interrater reliability of the SAPS, SANS and PANSS. Schizophr Res (1996) 0.97

Prevalence and diagnosis of schizophrenia based on register, case record and interview data in an isolated Finnish birth cohort born 1940-1969. Soc Psychiatry Psychiatr Epidemiol (2005) 0.96

Search for cognitive trait components of schizophrenia reveals a locus for verbal learning and memory on 4q and for visual working memory on 2q. Hum Mol Genet (2004) 0.96

Schizophrenia: an update and review. J Genet Couns (2005) 0.89

Affective flattening and alogia associate with the familial form of schizophrenia. Psychiatry Res (2006) 0.82

Clinical phenotype of schizophrenia in a Finnish isolate. Schizophr Res (2004) 0.79

Articles by these authors

Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25

Common variants conferring risk of schizophrenia. Nature (2009) 10.37

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet (2009) 7.45

Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44

Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63

Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry (2007) 6.20

Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet (2008) 4.78

Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol (2009) 3.92

Completed suicide after a suicide attempt: a 37-year follow-up study. Am J Psychiatry (2004) 3.92

A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am J Psychiatry (2011) 3.71

Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02

Mortality in schizophrenia: a measurable clinical endpoint. J Psychopharmacol (2010) 2.65

Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry (2006) 2.53

Incidence of schizophrenia in a nationwide cohort of patients with type 1 diabetes mellitus. Arch Gen Psychiatry (2007) 2.45

Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer (2011) 2.43

High concordance of bipolar I disorder in a nationwide sample of twins. Am J Psychiatry (2004) 2.24

Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet (2011) 2.21

A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord (2007) 2.16

The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual Life Res (2006) 2.16

Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ (2006) 2.14

Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Br J Psychiatry (2010) 2.09

Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am J Psychiatry (2002) 2.08

Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc Natl Acad Sci U S A (2007) 2.04

Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls. PLoS One (2010) 2.03

Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry (2004) 2.01

A population-specific HTR2B stop codon predisposes to severe impulsivity. Nature (2010) 2.00

Trends in self-reported sleep duration and insomnia-related symptoms in Finland from 1972 to 2005: a comparative review and re-analysis of Finnish population samples. J Sleep Res (2008) 1.94

Depressive symptoms in adolescence as predictors of early adulthood depressive disorders and maladjustment. Am J Psychiatry (2002) 1.93

Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry (2007) 1.93

Fertility of patients with schizophrenia, their siblings, and the general population: a cohort study from 1950 to 1959 in Finland. Am J Psychiatry (2003) 1.92

Genetic determinants of height growth assessed longitudinally from infancy to adulthood in the northern Finland birth cohort 1966. PLoS Genet (2009) 1.89

Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum Mol Genet (2003) 1.87

Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry (2012) 1.84

Spatial working memory as an endophenotype for schizophrenia. Biol Psychiatry (2003) 1.83

Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology (2002) 1.82

Is alexithymia a risk factor for major depression, personality disorder, or alcohol use disorders? A prospective population-based study. J Psychosom Res (2009) 1.72

Self-reported sleep duration and cognitive functioning in the general population. J Sleep Res (2009) 1.71

Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. J Clin Oncol (2009) 1.71

The relationship between job-related burnout and depressive disorders--results from the Finnish Health 2000 Study. J Affect Disord (2005) 1.67

The association between burnout and physical illness in the general population--results from the Finnish Health 2000 Study. J Psychosom Res (2006) 1.61

A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry (2007) 1.61

Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. J Clin Psychiatry (2007) 1.61

The relationship between performance and fMRI signal during working memory in patients with schizophrenia, unaffected co-twins, and control subjects. Schizophr Res (2006) 1.57

Geographic variation and sociodemographic characteristics of psychotic disorders in Finland. Schizophr Res (2008) 1.54

Age at onset and cognitive functioning in schizophrenia. Br J Psychiatry (2004) 1.54

Self-inflicted burns: an eight year retrospective study in Finland. Burns (2004) 1.52

Seasonal changes, sleep length and circadian preference among twins with bipolar disorder. BMC Psychiatry (2003) 1.51

Statin usage and all-cause and disease-specific mortality in a nationwide study. Pharmacoepidemiol Drug Saf (2011) 1.50

Premorbid intellectual functioning in bipolar disorder and schizophrenia: results from a cohort study of male conscripts. Am J Psychiatry (2005) 1.48

DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population--results from the Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol (2005) 1.48

Sex differences in cognition among persons with schizophrenia and healthy first-degree relatives. Psychiatry Res (2010) 1.46

Trajectories of mental health before and after old-age and disability retirement: a register-based study on purchases of psychotropic drugs. Scand J Work Environ Health (2012) 1.44

Self-reported sleep duration in Finnish general population. J Sleep Res (2006) 1.43

Associations between psychological well-being, mental health, and hormone therapy in perimenopausal and postmenopausal women: results of two population-based studies. Menopause (2013) 1.40

Partial remission indicates poor functioning and a high level of psychiatric symptoms: a 3-phase 6-year follow-up study on major depression. Nord J Psychiatry (2008) 1.40

Level of suicidal intent predicts overall mortality and suicide after attempted suicide: a 12-year follow-up study. BMC Psychiatry (2004) 1.39

Hippocampal volumes in schizophrenic twins. Arch Gen Psychiatry (2004) 1.37

Determinants and outcomes of serious attempted suicide: a nationwide study in Finland, 1996-2003. Am J Epidemiol (2008) 1.35

Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry (2003) 1.35

Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry (2002) 1.35

A twin study of genetic contributions to hippocampal morphology in schizophrenia. Neurobiol Dis (2002) 1.33

Genetic contributions to altered callosal morphology in schizophrenia. J Neurosci (2002) 1.33

Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes. Chronobiol Int (2013) 1.31

Poststroke depression: an 18-month follow-up. Stroke (2003) 1.31

Self-reported sleep duration, all-cause mortality, cardiovascular mortality and morbidity in Finland. Sleep Med (2011) 1.30

Families with the risk allele of DISC1 reveal a link between schizophrenia and another component of the same molecular pathway, NDE1. Hum Mol Genet (2006) 1.28